Does magnesium sulfate delay the active phase of labor in women with premature rupture of membranes? A randomized controlled trial
Author(s) -
Masoumeh Mirzamoradi,
Marzieh Behnam,
Tayebeh Jahed,
Soraya Salehgargari,
Mahmood Bakhtiyari
Publication year - 2014
Publication title -
taiwanese journal of obstetrics and gynecology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.518
H-Index - 35
eISSN - 1875-6263
pISSN - 1028-4559
DOI - 10.1016/j.tjog.2013.06.014
Subject(s) - medicine , prom , placebo , randomized controlled trial , premature rupture of membranes , adverse effect , pregnancy , azithromycin , gestational age , obstetrics , anesthesia , antibiotics , alternative medicine , microbiology and biotechnology , biology , genetics , pathology
Administration of many drugs including magnesium sulfate (MS) has considerable influences on pregnancy outcomes. The present study investigates the effects of MS administration on reaching the active phase of labor in women with premature rupture of membrane (PROM) and subsequent fetal complications.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom